JSPR logo

Jasper Therapeutics (JSPR) Company Overview

Profile

Full Name:

Jasper Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 10, 2020

Indexes:

Not included

Description:

Jasper Therapeutics is a biotechnology company focused on developing innovative therapies for patients with serious diseases. They specialize in creating treatments that use stem cell technology to improve patient outcomes, particularly in areas like blood disorders and cancer. Their goal is to enhance healing and recovery for those in need.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Mar 4, 2025

Recent annual earnings:

Mar 4, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 4, 2024

Analyst ratings

Recent major analysts updates

Feb 13, 25 UBS
Buy
Jan 10, 25 JMP Securities
Market Outperform
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 9, 25 RBC Capital
Outperform
Jan 6, 25 JMP Securities
Market Outperform
Dec 23, 24 RBC Capital
Outperform
Dec 6, 24 BMO Capital
Outperform
Oct 24, 24 HC Wainwright & Co.
Buy
Oct 15, 24 JMP Securities
Market Outperform
Oct 15, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Jasper Therapeutics?
  • Does Jasper Therapeutics pay dividends?
  • What sector is Jasper Therapeutics in?
  • What industry is Jasper Therapeutics in?
  • What country is Jasper Therapeutics based in?
  • When did Jasper Therapeutics go public?
  • Is Jasper Therapeutics in the S&P 500?
  • Is Jasper Therapeutics in the NASDAQ 100?
  • Is Jasper Therapeutics in the Dow Jones?
  • When was Jasper Therapeutics's last earnings report?
  • When does Jasper Therapeutics report earnings?
  • Should I buy Jasper Therapeutics stock now?

What is the ticker symbol for Jasper Therapeutics?

The ticker symbol for Jasper Therapeutics is NASDAQ:JSPR

Does Jasper Therapeutics pay dividends?

No, Jasper Therapeutics does not pay dividends

What sector is Jasper Therapeutics in?

Jasper Therapeutics is in the Healthcare sector

What industry is Jasper Therapeutics in?

Jasper Therapeutics is in the Biotechnology industry

What country is Jasper Therapeutics based in?

Jasper Therapeutics is headquartered in United States

When did Jasper Therapeutics go public?

Jasper Therapeutics's initial public offering (IPO) was on January 10, 2020

Is Jasper Therapeutics in the S&P 500?

No, Jasper Therapeutics is not included in the S&P 500 index

Is Jasper Therapeutics in the NASDAQ 100?

No, Jasper Therapeutics is not included in the NASDAQ 100 index

Is Jasper Therapeutics in the Dow Jones?

No, Jasper Therapeutics is not included in the Dow Jones index

When was Jasper Therapeutics's last earnings report?

Jasper Therapeutics's most recent earnings report was on Mar 4, 2025

When does Jasper Therapeutics report earnings?

The date for Jasper Therapeutics's next earnings report has not been announced yet

Should I buy Jasper Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions